Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| KCNE3 | Q9Y6H6 | Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (MiRP2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2) | Disease related genesHuman disease related genesPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| KCNG4 | Q8TDN1 | Voltage-gated potassium channel regulatory subunit KCNG4 (Potassium voltage-gated channel subfamily G member 4) (Voltage-gated potassium channel subunit Kv6.3) (Voltage-gated potassium channel subunit Kv6.4) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNK6 | Q9Y257 | Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence) | Predicted membrane proteinsTransportersVoltage-gated ion channels | 4 | Fusion and delivery mediation | 1 | 0.50 | |||
| KCNK9 | Q9NPC2 | Potassium channel subfamily K member 9 (Acid-sensitive potassium channel protein TASK-3) (TWIK-related acid-sensitive K(+) channel 3) (Two pore potassium channel KT3.2) (Two pore K(+) channel KT3.2) | 4 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNS1 | Q96KK3 | Delayed-rectifier potassium channel regulatory subunit KCNS1 (Delayed-rectifier K(+) channel alpha subunit 1) (Delayed-rectifier potassium channel subunit Kv9.1) (hKv9.1) (Potassium voltage-gated channel modifier subfamily S member 1) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNT1 | Q5JUK3 | Potassium channel subfamily T member 1 (KCa4.1) (KNa1.1) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.2) | Disease related genesHuman disease related genesPotential drug targetsPredicted membrane proteinsTransportersVoltage-gated ion channels | 6 | Acute myeloid leukaemiaHodgkin lymphoma | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| KIT | P10721 | Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117) | Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteins | 1 | Acute myeloid leukaemiaAlzheimer diseaseBone/articular cartilage neoplasmBrain cancerColorectal cancerGastrointestinal stromal tumourInflammatory arthropathyLiver cancerLung cancerMalignant intestine neoplasmMastocytosisMature B-cell lymphomaMultiple myelomaMyelodysplastic syndromeMyeloproliferative neoplasmPhakomatoses/hamartoneoplastic syndromePostoperative inflammationRenal cell carcinomaSolid tumour/cancerThrombocytopeniaTransplanted organ/tissue | Clinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||
| KPCD3 | O94806 | Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) | EnzymesPredicted intracellular proteins | Metabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| LAIR1 | Q6GTX8 | Leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) (hLAIR1) (CD antigen CD305) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 1 | Solid tumour/cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| LAMA4 | Q16363 | Laminin subunit alpha-4 (Laminin-14 subunit alpha) (Laminin-8 subunit alpha) (Laminin-9 subunit alpha) | Disease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted secreted proteins | Clinical-translation mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| LAT3 | O75387 | Large neutral amino acids transporter small subunit 3 (L-type amino acid transporter 3) (Prostate cancer overexpressed gene 1 protein) (Solute carrier family 43 member 1) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediation | 1 | 0.50 | |||
| LAX1 | Q8IWV1 | Lymphocyte transmembrane adapter 1 (Linker for activation of X cells) (Membrane-associated adapter protein LAX) | Predicted membrane proteins | 1 | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| LBN | Q86UK5 | Limbin (Ellis-van Creveld syndrome protein 2) (EVC2) | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| LCTL | Q6UWM7 | Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein) | 1 | Other mediation | 1 | 0.50 | ||||
| LEMD1 | Q68G75 | LEM domain-containing protein 1 (Cancer/testis antigen 50) (CT50) (LEM domain protein 1) (LEMP-1) | 1 | Other mediation | 1 | 0.50 | ||||
| LGR6 | Q9HBX8 | Leucine-rich repeat-containing G-protein coupled receptor 6 | G-protein coupled receptorsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 7 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| LIPI | Q6XZB0 | Lipase member I (LIPI) (EC 3.1.1.-) (Cancer/testis antigen 17) (CT17) (LPD lipase) (Membrane-associated phosphatidic acid-selective phospholipase A1-beta) (mPA-PLA1 beta) | Metabolism mediation | 1 | 0.50 | |||||
| LPAR4 | Q99677 | Lysophosphatidic acid receptor 4 (LPA receptor 4) (LPA-4) (G-protein coupled receptor 23) (P2Y purinoceptor 9) (P2Y9) (P2Y5-like receptor) (Purinergic receptor 9) | G-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 7 | Receptor-signaling mediation | 1 | 0.50 | |||
| LRC26 | Q2I0M4 | Leucine-rich repeat-containing protein 26 (BK channel auxiliary gamma subunit LRRC26) (Cytokeratin-associated protein in cancer) | Predicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| LRTM3 | Q8NDH2 | Leucine-rich repeat transmembrane protein 3 (Coiled-coil domain-containing protein 168) | Predicted membrane proteins | 1 | Other mediation | 1 | 0.50 | |||
| LSHR | P22888 | Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LHR) (LSH-R) | Disease related genesFDA approved drug targetsG-protein coupled receptorsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins | 7 | Female infertilityHeart diseaseLeukaemiaMale infertilityMyelodysplastic syndromePituitary gland disorderSolid tumour/cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||
| LSR | Q86X29 | Lipolysis-stimulated lipoprotein receptor (Angulin-1) | Disease related genesPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.50 | |||
| LST1 | O00453 | Leukocyte-specific transcript 1 protein (Protein B144) | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | ||||
| LST2 | Q9HCC9 | Lateral signaling target protein 2 homolog (hLst2) (Zinc finger FYVE domain-containing protein 28) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| LT4R2 | Q9NPC1 | Leukotriene B4 receptor 2 (LTB4-R 2) (LTB4-R2) (LTB4 receptor JULF2) (Leukotriene B4 receptor BLT2) (Seven transmembrane receptor BLTR2) | G-protein coupled receptorsPredicted membrane proteins | 7 | AsthmaHuman immunodeficiency virus diseaseIndeterminate colitisRenal cell carcinoma | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.50 |